Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

500 ALS patients join hunt for biomarkers to predict disease course

NCT ID NCT02360891

First seen May 05, 2026 · Last updated May 22, 2026 · Updated 3 times

Summary

This study looked at 500 people with ALS (a nerve disease that weakens muscles) to find signs—called biomarkers—that could predict how fast the disease will progress and how long patients might live. Researchers collected medical images, blood samples, and electrical tests of nerves and muscles. The goal was to build a large database to help design better future treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • AP-HM,Hôpital de la Timone

    Marseille, France

  • CHRU, Hôpital Salengro

    Lille, France

  • CHU Bretonneau

    Tours, France

  • CHU Cote de Nacre

    Caen, France

  • CHU Gabriel Montpied

    Clermont-Ferrand, France

  • CHU Pontchaillou

    Angers, France

  • Centre Hospitalier

    Saint-Brieuc, France

  • Hôpital Dupuytren

    Limoges, France

  • Hôpital Gui de Chauliac

    Montpellier, France

  • Hôpital La Pitié (AP-HP)

    Paris, France

  • Hôpital Neurologique Pierre Wertheimer

    Lyon, France

  • Hôpital Nord

    Saint-Etienne, France

  • Hôpital de l'Archet 1, CHU

    Nice, France

Conditions

Explore the condition pages connected to this study.